Johnson & Johnson MedTech plans to submit its Ottava robotic surgical system for an investigational device exemption application to the FDA in the second half of 2024 to begin clinical trials.
What J&J's new surgical robot could mean for ASCs
Johnson & Johnson MedTech plans to submit its Ottava robotic surgical system for an investigational device exemption application to the FDA in the second half of 2024 to begin clinical trials.